BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 1968925)

  • 1. IL-4 inhibits IL-2 receptor expression and IL-2-dependent proliferation of human T cells.
    Martinez OM; Gibbons RS; Garovoy MR; Aronson FR
    J Immunol; 1990 Mar; 144(6):2211-5. PubMed ID: 1968925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation.
    de Waal Malefyt R; Yssel H; de Vries JE
    J Immunol; 1993 Jun; 150(11):4754-65. PubMed ID: 7684412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.
    Woods M; Guy R; Waldmann H; Glennie M; Alexander DR
    Cell Immunol; 1998 May; 185(2):101-13. PubMed ID: 9636688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of cytokines on proliferative response of human CD4+ T lymphocyte subsets stimulated via T cell receptor-CD3 complex.
    Wasik MA; Morimoto C
    J Immunol; 1990 May; 144(9):3334-40. PubMed ID: 1691754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trypanosoma cruzi inhibits the expression of CD3, CD4, CD8, and IL-2R by mitogen-activated helper and cytotoxic human lymphocytes.
    Sztein MB; Cuna WR; Kierszenbaum F
    J Immunol; 1990 May; 144(9):3558-62. PubMed ID: 2139458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective clonogenic potential of CD8+ T lymphocytes in patients with AIDS. Expansion in vivo of a nonclonogenic CD3+CD8+DR+CD25- T cell population.
    Pantaleo G; Koenig S; Baseler M; Lane HC; Fauci AS
    J Immunol; 1990 Mar; 144(5):1696-704. PubMed ID: 2137842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD28 is an inducible T cell surface antigen that transduces a proliferative signal in CD3+ mature thymocytes.
    Turka LA; Ledbetter JA; Lee K; June CH; Thompson CB
    J Immunol; 1990 Mar; 144(5):1646-53. PubMed ID: 2155264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the mechanisms of T cell-dependent polyclonal activation of human B cells. Induction of human B cell responses by fixed activated T cells.
    Tohma S; Lipsky PE
    J Immunol; 1991 Apr; 146(8):2544-52. PubMed ID: 1707911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of murine T cell subsets with anti-CD3 antibody. Age-related defects in the expression of early activation molecules.
    Ernst DN; Weigle WO; McQuitty DN; Rothermel AL; Hobbs MV
    J Immunol; 1989 Mar; 142(5):1413-21. PubMed ID: 2521878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-T12, an anti-CD6 monoclonal antibody, can activate human T lymphocytes.
    Gangemi RM; Swack JA; Gaviria DM; Romain PL
    J Immunol; 1989 Oct; 143(8):2439-47. PubMed ID: 2794503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-stimulation of T cell proliferation by transforming growth factor-beta 1.
    Lee HM; Rich S
    J Immunol; 1991 Aug; 147(4):1127-33. PubMed ID: 1831218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-2 protects against anti-CD3-induced cell death in human medullary thymocytes.
    Nieto MA; González A; López-Rivas A; Diaz-Espada F; Gambón F
    J Immunol; 1990 Sep; 145(5):1364-8. PubMed ID: 1974564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolated peripheral T cells from GvHR recipients exhibit defective IL-2R expression, IL-2 production, and proliferation in response to activation stimuli.
    Levy RB; Jones M; Cray C
    J Immunol; 1990 Dec; 145(12):3998-4005. PubMed ID: 1979582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation via the CD3 and CD28 molecules induces responsiveness to IL-4 in CD4+CD29+CD45R- memory T lymphocytes.
    Damle NK; Doyle LV
    J Immunol; 1989 Sep; 143(6):1761-7. PubMed ID: 2570801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA class II molecules on monocytes regulate T cell proliferation through physical interaction in the CD3 activation pathway.
    Ruggiero G; Racioppi L; Manzo C; Pirozzi G; D'Oro U; Ferrone S; Zappacosta S; Fontana S
    Eur J Immunol; 1991 Jan; 21(1):29-33. PubMed ID: 1825060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis of activated CD8+/CD57+ T cells is induced by some combinations of anti-CD2 mAb.
    Rouleau M; Bernard A; Lantz O; Vernant JP; Charpentier B; Senik A
    J Immunol; 1993 Oct; 151(7):3547-56. PubMed ID: 7690806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct regulatory effects of IL-4 and TNF-alpha during CD3-dependent and CD3-independent initiation of human T-cell activation.
    Damle NK; Doyle LV
    Lymphokine Res; 1989; 8(2):85-97. PubMed ID: 2525210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the interleukin 2 pathway precedes CD3-T cell receptor expression in thymic development. Differential growth requirements of early and mature intrathymic subpopulations.
    Toribio ML; De la Hera A; Marcos MA; Márquez C; Martínez C
    Eur J Immunol; 1989 Jan; 19(1):9-15. PubMed ID: 2522051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comitogenic effect of solid-phase immobilized anti-1F7 on human CD4 T cell activation via CD3 and CD2 pathways.
    Dang NH; Torimoto Y; Deusch K; Schlossman SF; Morimoto C
    J Immunol; 1990 Jun; 144(11):4092-100. PubMed ID: 1971293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous ligation of CD5 and CD28 on resting T lymphocytes induces T cell activation in the absence of T cell receptor/CD3 occupancy.
    Verwilghen J; Vandenberghe P; Wallays G; de Boer M; Anthony N; Panayi GS; Ceuppens JL
    J Immunol; 1993 Feb; 150(3):835-46. PubMed ID: 7678624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.